Health Care & Life Sciences » Pharmaceuticals | Yabao Pharmaceutical Group Co. Ltd.

Yabao Pharmaceutical Group Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
113,259.70
165,106.70
218,048.20
27,040.70
199,820.70
284,019.70
Depreciation, Depletion & Amortization
93,428.80
125,916.70
136,483.40
158,368.90
176,908.00
170,598.80
Other Funds
45,317.40
50,165.20
727,763.00
35,137.70
42,673.40
22,409.90
Funds from Operations
233,754.70
346,351.00
400,329.40
173,645.30
432,589.30
473,487.20
Changes in Working Capital
175,291.60
166,308.50
254,854.40
16,857.10
270,164.70
78,039.30
Net Operating Cash Flow
58,463.10
180,042.60
145,475.00
156,788.20
162,424.60
395,447.90
Capital Expenditures
99,015.10
173,841.10
101,675.90
84,464.50
99,341.30
Sale of Fixed Assets & Businesses
32,975.10
11,088.10
234.50
92,974.90
1,309.60
Purchase/Sale of Investments
1,359,875.10
43,126.30
16,461.90
13,146.50
23,640.10
Net Investing Cash Flow
57,683.10
205,879.30
84,979.50
588,265.30
121,671.90
Cash Dividends Paid - Total
34,600.00
41,520.00
124,560.00
78,704.10
15,740.80
Issuance/Reduction of Debt, Net
145,827.00
264,673.00
127,446.30
56,654.50
83,172.70
Net Financing Cash Flow
65,909.60
356,358.20
730,649.30
57,187.30
141,587.00
Net Change in Cash
66,702.10
382,230.10
790,820.50
488,786.60
100,816.20
Free Cash Flow
40,552.00
6,201.40
43,799.10
72,323.80
63,083.30
Deferred Taxes & Investment Tax Credit
830.90
917.40
985.50
8,373.30
5,988.60
3,541.20
Net Assets from Acquisitions
10,787.80
-
-
609,922.30
-
Other Sources
1,379,019.80
-
-
-
-
Exchange Rate Effect
12.50
35.20
324.30
122.20
18.00

About Yabao Pharmaceutical Group Co.

View Profile
Address
11/F, Building 2, Yard 11
Beijing Beijing 100176
China
Employees -
Website http://www.yabao.com.cn
Updated 07/08/2019
Yabao Pharmaceutical Group Co., Ltd. engages in the development, production, and sale of pharmaceutical products. It focuses on medicine and health business. The company's products include Chinese and western medicine preparations, raw materials, and pharmaceutical packaging materials, mainly for the elderly chronic drug and women and children medication; cardiovascular and cerebrovascular drugs, and health products.